Receptor tyrosine kinases in carcinogenesis.

about

Current progress in innovative engineered antibodies.Twist promotes tumor metastasis in basal-like breast cancer by transcriptionally upregulating ROR1.

P2860

Q40077818-1FF177B9-6AD9-4DF9-AC8F-E7FEFBA5264A Q55039454-B83A35AC-0ECE-4D12-9D9C-F6FB423B559B

P2860

Receptor tyrosine kinases in carcinogenesis.

Item

http://www.wikidata.org/entity/Q39024002

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Receptor tyrosine kinases in carcinogenesis.

@en

Receptor tyrosine kinases in carcinogenesis.

@nl

type

Item

label

Receptor tyrosine kinases in carcinogenesis.

@en

Receptor tyrosine kinases in carcinogenesis.

@nl

prefLabel

Receptor tyrosine kinases in carcinogenesis.

@en

Receptor tyrosine kinases in carcinogenesis.

@nl

P1476

Receptor tyrosine kinases in carcinogenesis.

@en

P2093

Pei-Ying Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-Ying Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma

Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential

ROR1, an embryonic protein with an emerging role in cancer biology

Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study.

Receptor tyrosine kinase signalling as a target for cancer intervention strategies

Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies

Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells.

ROR1 expression correlated with poor clinical outcome in human ovarian cancer

P304

3679-3682

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.5200

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27900053

http://www.w3.org/2001/XMLSchema#string

P932

5104145

http://www.w3.org/2001/XMLSchema#string

Receptor tyrosine kinases in carcinogenesis.

about

P2860

P2860

Receptor tyrosine kinases in carcinogenesis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932